Neurocrine Biosciences Appoints Chief Technical Operations Officer

MT Newswires Live03-18

Neurocrine Biosciences (NBIX) said late Tuesday it named Andrew Ratz as chief technical operations officer.

He was most recently the senior vice president of drug development, delivery, and device at the company, according to a statement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment